HHS Announces Key Leadership Selections at FDA to Promote Innovation, Reform, and National Health Priorities

WASHINGTON, D.C. — September 8, 2026 — The U.S. Department of Health and Human Services today announced the selection of four senior leaders at the U.S. Food and Drug Administration (FDA), strengthening the agency’s leadership team as FDA advances its public health pillars to deliver profound benefits for patients, consumers, and public health. These appointments reflect a deliberate strategy to drive innovation and meaningful reform across FDA, positioning the Agency to lead on its core priorities: advancing innovation and global leadership, strengthening national health security, increasing access to affordable medicines and medical products, and promoting health wellness for the American people.

Continue reading

This Fast Lane Company is Saving Lives One Heart at a Time

A vital lifeline to patients facing end-stage biventricular heart failure.

For millions of people worldwide, cardiac health is something taken for granted—a steady, rhythmic beat keeping life in motion. But for patients diagnosed with advanced biventricular heart failure, that rhythm slows to a dangerous point. When both the left and right ventricles can no longer pump enough blood to sustain vital organs, the threat of imminent death becomes an immediate reality.

In these critical moments, modern medical technology steps in with a groundbreaking solution: the SynCardia Total Artificial Heart (STAH)Continue reading

Precision Epigenomics Named an AZBio Fast Lane Company

Detecting Cancer Before It Starts: How One Arizona Startup Is Transforming Precision Oncology

In modern medicine, early cancer detection remains a central goal. Identifying a tumor before symptoms emerge often makes the difference between routine intervention and a terminal diagnosis.

Standing at the leading edge of this shift is Precision Epigenomics, a Tucson-based bioscience startup whose rapid trajectory over the past 18 months is drawing national attention. Through cutting-edge liquid biopsy technology, rigorous laboratory standards, and high-impact strategic partnerships, the company is turning complex epigenetic science into life-saving clinical tools.Continue reading